# A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo Followed by a Voluntary Open Label Extension for Safety.

> **NCT00364247** · PHASE3 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 602 (actual)

## Conditions studied

- Arthralgia
- Bunion
- Hallux Valgus
- Pain Assessment
- Tapentadol

## Interventions

- **DRUG:** CG5503 IR;tapentadol

## Key facts

- **NCT ID:** NCT00364247
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 602 (ACTUAL)
- **Last updated:** 2011-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00364247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00364247, "A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo Followed by a Voluntary Open Label Extension for Safety.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00364247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*